In last trading session, Aldeyra Therapeutics Inc (NASDAQ:ALDX) saw 1.05 million shares changing hands with its beta currently measuring 1.12. Company’s recent per share price level of $2.42 trading at $0.1 or 4.31% at ring of the bell on the day assigns it a market valuation of $144.49M. That closing price of ALDX’s stock is at a discount of -197.52% from its 52-week high price of $7.20 and is indicating a premium of 52.89% from its 52-week low price of $1.14. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.98 million shares which gives us an average trading volume of 1.50 million if we extend that period to 3-months.
For Aldeyra Therapeutics Inc (ALDX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Aldeyra Therapeutics Inc (NASDAQ:ALDX) trade information
Upright in the green during last session for gaining 4.31%, in the last five days ALDX remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $2.42 price level, adding 4.35% to its value on the day. Aldeyra Therapeutics Inc’s shares saw a change of -51.50% in year-to-date performance and have moved 10.00% in past 5-day. Aldeyra Therapeutics Inc (NASDAQ:ALDX) showed a performance of -63.39% in past 30-days. Number of shares sold short was 3.55 million shares which calculate 3.87 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 11 to the stock, which implies a rise of 78.0% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would drop -313.22% in reaching the projected high whereas dropping to the targeted low would mean a loss of -313.22% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 15.99% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 16.10% while estimates for its earnings growth in next 5 years are of 37.68%.
Aldeyra Therapeutics Inc (NASDAQ:ALDX)’s Major holders
Insiders are in possession of 2.43% of company’s total shares while institution are holding 55.29 percent of that, with stock having share float percentage of 56.67%. Investors also watch the number of corporate investors in a company very closely, which is 55.29% institutions for Aldeyra Therapeutics Inc that are currently holding shares of the company. PERCEPTIVE ADVISORS LLC is the top institutional holder at ALDX for having 9.28 million shares of worth $30.7 million. And as of 2024-06-30, it was holding 15.6121 of the company’s outstanding shares.
The second largest institutional holder is KNOLL CAPITAL MANAGEMENT, LLC, which was holding about 5.48 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2158 of outstanding shares, having a total worth of $18.12 million.
